开发一种抑制性单克隆纳米体,针对Streptococcus pyogenes siderophore结合蛋白 FtsB 的开发
Jorge Fernandez-Perez1, Susana de Vega2, Jose M M Caaveiro3
1Department of Bioengineering, School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
The Journal of biological chemistry
|February 6, 2026
概括
研究人员开发了一种向Streptococcus pyogenes中的FtsB蛋白的纳米体. 这种纳米体抑制铁酸盐的吸收,为研究细菌铁运输和对抗感染提供了一个新的工具.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 免疫学 免疫学 免疫学
背景情况:
- 病原性细菌需要金属载体来感染.
- 斯氏菌使用FtsABCD系统来吸收铁酸盐.
- 在S. pyogenes感染中FtsABCD的确切作用尚未完全理解.
研究的目的:
- 开发一种针对Streptococcus pyogenes中FtsABCD铁载体的新型抑制剂.
- 调查纳米体对FTSB的结合特性和抑制潜力.
主要方法:
- 一个单克隆阿尔帕卡VHH纳米体 (Nb1) 的开发,针对FtsB.
- 描述Nb1结合动力学和热力学.
- HDX-MS,突变分析和X射线晶体学以确定表位.
- 在体外测定以评估 siderophore 结合和吸收的抑制.
主要成果:
- Nb1与FtsB结合,具有nM以下的亲和力和缓慢的解离率.
- Nb1的表位位于FtsB的结合口袋内.
- Nb1可以竞争性地抑制酸的 siderophore 结合,并部分抑制 S. pyogenes 中的 siderophore 吸收.
结论:
- Nb1是FtsABCD载体的一个强有力的抑制剂.
- Nb1是研究细菌铁运输的一个有价值的工具.
- 在铁有限的条件下,Nb1显示出作为抗菌剂对抗S. pyogenes的潜力.
相关概念视频
Factors Affecting Protein-Drug Binding: Protein-Related Factors
575
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
575
The Equilibrium Binding Constant and Binding Strength
15.1K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.1K
Drug Distribution: Plasma Protein Binding
9.0K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
9.0K
Protein-Drug Binding: Determination Methods
659
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
659
Single-Strand DNA Binding Proteins
16.7K
For successful DNA replication, the unwinding of double-stranded DNA must be accompanied by stabilization and protection of the separated single strands of the DNA. This crucial task is performed by single-strand DNA-binding (SSB) proteins. They bind to the DNA in a sequence-independent manner, which means that the nitrogenous bases of the DNA need not be present in a specific order for binding of SSB proteins to it. The binding of SSB proteins straightens single-stranded DNA (ssDNA) and makes...
16.7K
Protein-Drug Binding: Mechanism and Kinetics
1.8K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.8K


